Bernard J. Zovighian

Bernard Zovighian is CEO and a director of Edwards Lifesciences, Inc.(EW) after serving as president since January 2023. Prior to this leadership transition, Mr. Zovighian served since January 2018 as corporate vice president responsible for the company’s Transcatheter Mitral and Tricuspid Therapies (TMTT) business. As the leader for TMTT, he established a global organization focused on developing and delivering a portfolio of therapies designed to change the standard of care for mitral and tricuspid patients. Mr. Zovighian joined Edwards Lifesciences in January 2015 as vice president and general manager of the Surgical Structural Heart business, the company’s foundational organization dedicated to innovating surgical heart valve therapies. He later served as corporate vice president of the surgical business from 2016 until he began leading TMTT. In his nearly 30-year career in medical technology, Mr. Zovighian spent 12 years leading global businesses across two world-class companies.